GNMK - GenMark Diagnostics, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5354.87M
Enterprise Value 3379.8M
Trailing P/E N/A
Forward P/E 1-10.91
PEG Ratio (5 yr expected) 10.18
Price/Sales (ttm)4.73
Price/Book (mrq)23.77
Enterprise Value/Revenue 35.06
Enterprise Value/EBITDA 6-10.32

Trading Information

Stock Price History

Beta (3Y Monthly) 1.77
52-Week Change 3-16.67%
S&P500 52-Week Change 31.68%
52 Week High 38.81
52 Week Low 33.58
50-Day Moving Average 36.37
200-Day Moving Average 36.84

Share Statistics

Avg Vol (3 month) 3334.71k
Avg Vol (10 day) 3249.6k
Shares Outstanding 555.96M
Float 45.44M
% Held by Insiders 16.60%
% Held by Institutions 195.90%
Shares Short (Jul 31, 2019) 42.29M
Short Ratio (Jul 31, 2019) 45.98
Short % of Float (Jul 31, 2019) 45.93%
Short % of Shares Outstanding (Jul 31, 2019) 43.99%
Shares Short (prior month Jun 28, 2019) 42.02M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019


Profit Margin -63.86%
Operating Margin (ttm)-58.60%

Management Effectiveness

Return on Assets (ttm)-29.72%
Return on Equity (ttm)-148.83%

Income Statement

Revenue (ttm)75.08M
Revenue Per Share (ttm)1.33
Quarterly Revenue Growth (yoy)23.00%
Gross Profit (ttm)19.48M
Net Income Avi to Common (ttm)-47.94M
Diluted EPS (ttm)-0.85
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)41.36M
Total Cash Per Share (mrq)0.72
Total Debt (mrq)56.42M
Total Debt/Equity (mrq)381.74
Current Ratio (mrq)3.39
Book Value Per Share (mrq)0.26

Cash Flow Statement

Operating Cash Flow (ttm)-31.69M
Levered Free Cash Flow (ttm)-14.11M